Carl Le Bel Frequency Therapeutics, Inc. (FREQ) insider trading activity

Carl Le Bel is Chief Development Officer of Frequency Therapeutics, Inc.. Currently has a direct ownership of 26,343 shares of FREQ, which is worth approximately $0. The most recent transaction as insider was on Jul 06, 2022, when has been sold 4,421 shares (Common Stock) at a price of $1.52 per share, resulting in proceeds of $6,720. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.3K

0% 3M change

0% 12M change

Total Value Held $0

Carl LeBel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 06 2022	SELL Open market or private sale	$6,720 $1.52 p/Share	4,421 Reduced 14.37%	26,343 Common Stock
Jul 05 2022	BUY Exercise of conversion of derivative security	-	15,000 Added 32.78%	30,764 Common Stock
Feb 22 2022	SELL Open market or private sale	$3,774 $3.53 p/Share	1,069 Reduced 8.77%	11,126 Common Stock
Feb 18 2022	SELL Open market or private sale	$3,769 $3.87 p/Share	974 Reduced 7.4%	12,195 Common Stock
Feb 17 2022	SELL Open market or private sale	$3,775 $4.19 p/Share	901 Reduced 6.4%	13,169 Common Stock
Feb 16 2022	SELL Open market or private sale	$3,681 $4.43 p/Share	831 Reduced 5.58%	14,070 Common Stock
Feb 15 2022	SELL Open market or private sale	$3,655 $4.33 p/Share	844 Reduced 5.36%	14,901 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	-	15,000 Added 48.79%	15,745 Common Stock

Carl Le Bel

Chief Development Officer

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FREQ shares.

Notify only if

Value

Insider Trading

Get notified when an Frequency Therapeutics, Inc. insider buys or sells FREQ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Frequency Therapeutics, Inc.

Track Activities on FREQ

Account